Biovica International7,13 SEK −1,66 %
Biovica International is a pharmaceutical company that focuses its research on the treatment of solid tumors. The company is developing methods for measuring cell proliferation, where the test is taken via blood samples. The tests analyze the risk for the development of the enzyme thymidine kinase, an enzyme that is linked to tumor growth. The company was founded in 2008 and is headquartered in Uppsala.